Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: an update.

M I Merican1

  • 1Academic Department of Medicine, Royal Free Hospital, Hampstead London.

The Medical Journal of Malaysia
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) identification revolutionized diagnostics and epidemiology. While interferon shows promise, further antiviral research is needed for effective Hepatitis C treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Good clinical practice: issues and challenges.

The Medical journal of Malaysia·2009
Same author

Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C.

Journal of viral hepatitis·2009
Same author

Developing the Malaysian health system to meet the challenges of the future.

The Medical journal of Malaysia·2004
Same author

Management of variceal haemorrhage.

The Medical journal of Malaysia·1992
Same author

Management of heatstroke in Malaysian pilgrims in Saudi Arabia.

The Medical journal of Malaysia·1989
Same journal

Diagnostic performance of computed tomography colonography following incomplete colonoscopy and its associated factors: A single-centre retrospective study.

The Medical journal of Malaysia·2026
Same journal

Gender representation across surgical specialties in Malaysia.

The Medical journal of Malaysia·2026
Same journal

Non-specific orbital inflammation: Clinical and histopathological insights from a 6-year single-centre Malaysian cohort.

The Medical journal of Malaysia·2026
Same journal

Prevalence of metabolic associated fatty liver disease (MAFLD) and its associated factors among type 2 diabetes mellitus (T2DM) in primary care settings in Kuantan, Pahang.

The Medical journal of Malaysia·2026
Same journal

Sixteen years of cochlear implant surgery in cochleovestibular malformation and cochlear nerve deficiency: Insights from northern Malaysia.

The Medical journal of Malaysia·2026
Same journal

Evaluation of vision-related quality of life and its associated factors in patients with diabetic vitreoretinal disease post trans pars plana vitrectomy using visual functioning questionnaire-25.

The Medical journal of Malaysia·2026
See all related articles

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) identification marked a significant advancement, replacing the term Non-A Non-B Hepatitis.
  • This discovery enabled specific antibody detection assays, facilitating sero-epidemiological studies of HCV infection.

Purpose of the Study:

  • To outline the epidemiology and diagnostic approaches for Hepatitis C virus (HCV).
  • To review current treatment strategies and future therapeutic directions for Hepatitis C.

Main Methods:

  • Utilized molecular cloning for Hepatitis C virus identification.
  • Reviewed diagnostic tests including ELISA anti-HCV, recombinant immunoblot assay, HCV-RNA by PCR, and HCV-Ag.
  • Examined sero-epidemiological data on Hepatitis C antibody carriage and transmission routes.

Related Experiment Videos

Main Results:

  • Hepatitis C antibody carriage varies globally, with highest prevalence in intravenous drug users and hemophiliacs.
  • Parenteral transmission is primary; sexual, familial, and perinatal routes are less common. Approximately 40% are community-acquired.
  • Over 50% of acute cases become chronic, with 20% progressing to cirrhosis and potential hepatocellular carcinoma.

Conclusions:

  • Interferon therapy shows some efficacy but has a 50% relapse rate.
  • Further clinical trials with interferon and antivirals like ribavirin are essential for improved Hepatitis C treatment outcomes.